Other than this, I have no idea. Just a turd with wings::
XTL Biopharmaceuticals Ltd. Completes Acquisition Of Bio-Gal
Wednesday, 4 Aug 2010 04:29pm EDT
XTL Biopharmaceuticals Ltd. announced that their purchase of Bio-Gal was completed. Under the terms of the purchase, XTL has obtained the exclusive license for the rights to a use-patent on Erythropoietin for the treatment of multiple myeloma patients, against an allocation of approximately 69% of its shares. Furthermore, XTL obtained USD1.5 million, which was raised from Bio-Gal's shareholders and private investors.